Global CRO footprint TFS HealthScience is a full-service global CRO with operations across 50 countries, offering strategic resourcing and clinical development services in dermatology, internal medicine, neuroscience, oncology, and ophthalmology. Sales opportunity: leverage their wide geographic reach to propose multicenter trials and region-specific patient access programs for sponsors expanding internationally.

Strategic partnerships The company emphasizes strategic partnerships and tailored resourcing solutions, suggesting an openness to co-development, vendor consolidation, and flexible engagement models. Sales opportunity: position integrated service packages that streamline vendor management and align with sponsor timelines and budget constraints.

Recent leadership shifts Key leadership changes, including the appointment of a new CEO and VP of Business Development, signal a potential shift in strategic focus and growth initiatives. Sales opportunity: engage proactively with decision-makers to align offerings with any new strategic priorities, expansion plans, or channel partnerships.

Expansion in oncology focus Recent leadership appointment of a VP Head of Oncology & Rare Diseases and historical activity in oncology-related acquisitions and partnerships indicate a strengthened emphasis on oncology and related rare diseases. Sales opportunity: tailor discussions around oncology trial design, patient recruitment for rarer indications, and access to specialized trial resources.

Technology-enabled trials The collaboration with Paradigm Application Solutions and use of tech stack elements (AI-enabled partnerships, data and systems integration) point to a tech-forward approach to clinical development. Sales opportunity: propose digital trial solutions, AI-driven data management, remote monitoring, and integrated analytics to improve trial efficiency and data quality.